Regulation of corticotropin-releasing factor receptor messenger ribonucleic acid in rat anterior pituitary.
Adrenalectomy (ADX) leads to a decrease in the number of CRF-binding sites in the rat anterior pituitary (AP). However, the molecular mechanisms of CRF receptor (CRF-R) regulation are unknown. In the present study, we analyzed the effects of ADX on pituitary CRF- R1 messenger RNA (mRNA) levels in vivo and the direct effects of CRF, arginine vasopressin (AVP), and glucocorticoid, the levels of which are altered by ADX, on CRF- R1 mRNA levels in vitro. The mRNA level was determined by Northern blot analysis using a rat brain CRF- R1 complementary RNA probe. The CRF- R1 level in AP fell to 20% of the sham level 1 day after ADX and returned to the sham level after 14 days. In cultured rat AP cells, treatment with CRF, AVP, and dexamethasone led to significant reductions in CRF- R1 mRNA, with maximal inhibition to 32%, 22%, and 37% of control levels, respectively. The time course of CRF- R1 mRNA reduction varied depending on the drug, with effects detectable as early as 1 h after treatment. These findings indicate that elevated portal CRF and AVP levels may contribute to the decrease in CRF- R1 mRNA soon after ADX. A decrease in mRNA levels, in turn, may lead to a decrease in CRF- R1 protein on corticotrophs.[1]References
- Regulation of corticotropin-releasing factor receptor messenger ribonucleic acid in rat anterior pituitary. Sakai, K., Horiba, N., Sakai, Y., Tozawa, F., Demura, H., Suda, T. Endocrinology (1996) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
